Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1041344

registered interest
date	16/01/2019
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	High Rise Flats: Fires
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what estimate he has made of the number of fires in (a) publicly and (b) privately owned high rise residential blocks in each of the last 20 years.
tabling member constituency	Croydon Central
tabling member printed	Sarah Jones
uin	208350
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>The Home Office do not hold this information.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 17/01/2019 17:39:12 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4631 label Biography information for Sarah Jones

1042203

registered interest
date	16/01/2019
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Food: Labelling
house id	1
legislature	25259 pref label House of Commons
question text	When his Department plans to respond to its consultation entitled Food labelling: amending laws.
tabling member constituency	East Dunbartonshire
tabling member printed	Jo Swinson
uin	908633
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>Defra intends to provide a summary of responses and the Government response by 7 February as set out on the consultation web page.</p><p> </p> answering member constituency Macclesfield answering member printed David Rutley question first answered 17/01/2019 17:46:13 answering member 4033 label Biography information for David Rutley
tabling member	1513 label Biography information for Jo Swinson

1042204

registered interest
date	16/01/2019
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Nature Conservation
house id	1
legislature	25259 pref label House of Commons
question text	What recent discussions he has had with the Foreign Secretary on the protection of endangered species.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	908630
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>Ministers regularly meet with the Foreign Secretary to discuss international species conservation issues. Our close working delivered the highly successful Illegal Wildlife Trade Conference in London in October last year, which brought together global leaders to drive forward action to end this despicable trade. Our ban on ivory sales through the Ivory Act is one of the toughest in the world and demonstrates our joint leadership to galvanise action around the world.</p> answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey question first answered 17/01/2019 16:14:23 answering member 4098 label Biography information for Dr Thérèse Coffey
tabling member	4498 label Biography information for Mr Ranil Jayawardena

1041248

registered interest
date	14/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department's plans to ensure the supply of medicines in the event of the UK leaving the EU without a deal (a) have been or (b) will be subjected to an independent evaluation.
tabling member constituency	Ilford North
tabling member printed	Wes Streeting
uin	208297
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>The Department’s plans to ensure the supply of medicines in the event of the United Kingdom leaving the European Union without a deal have been subject to scrutiny by a number of Parliamentary Committees, including the Public Accounts Committee, the Health and Social Care Committee, the EU Exit Committee and the House of Lords EU Home Affairs Sub-Committee. The Department is also working closely with suppliers, their supply chains, health services and devolved administrations to maintain the continuity of medicines supply in a ‘no deal’ EU exit scenario.</p><p> </p><p>We are unable to publish the list of medicines requested. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s contingency programme. That means not introducing information about a specific company, medicine or supply route into the public domain.</p><p> </p><p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU or European Economic Area (EEA), asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. We recognise, however, that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>Additionally, on 7 December 2018, the Department wrote to pharmaceutical companies that supply licensed medicines to the UK from or via the EU/EEA and/or manufacture medicines in the UK, informing them of the updated reasonable worst-case scenario border disruption planning assumptions and asking them about their current transportation routes and their ability to re-route their supply chains if they currently rely on Dover and/or Folkestone.</p><p> </p><p>We have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and that suppliers are able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ exit.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 208298 question first answered 17/01/2019 16:27:06 answering member 1585 label Biography information for Stephen Hammond
tabling member	4504 label Biography information for Wes Streeting

1041249

registered interest
date	14/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish (a) a list of medicines for which there is a supply risk in the event of the UK leaving the EU without a deal and (b) a plan to mitigate those supply risks.
tabling member constituency	Ilford North
tabling member printed	Wes Streeting
uin	208298
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>The Department’s plans to ensure the supply of medicines in the event of the United Kingdom leaving the European Union without a deal have been subject to scrutiny by a number of Parliamentary Committees, including the Public Accounts Committee, the Health and Social Care Committee, the EU Exit Committee and the House of Lords EU Home Affairs Sub-Committee. The Department is also working closely with suppliers, their supply chains, health services and devolved administrations to maintain the continuity of medicines supply in a ‘no deal’ EU exit scenario.</p><p> </p><p>We are unable to publish the list of medicines requested. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s contingency programme. That means not introducing information about a specific company, medicine or supply route into the public domain.</p><p> </p><p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU or European Economic Area (EEA), asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. We recognise, however, that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>Additionally, on 7 December 2018, the Department wrote to pharmaceutical companies that supply licensed medicines to the UK from or via the EU/EEA and/or manufacture medicines in the UK, informing them of the updated reasonable worst-case scenario border disruption planning assumptions and asking them about their current transportation routes and their ability to re-route their supply chains if they currently rely on Dover and/or Folkestone.</p><p> </p><p>We have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and that suppliers are able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ exit.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 208297 question first answered 17/01/2019 16:27:06 answering member 1585 label Biography information for Stephen Hammond
tabling member	4504 label Biography information for Wes Streeting

1041257

registered interest
date	14/01/2019
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Armed Forces: Mefloquine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, when he plans to reach a final conclusion on the effect on veterans' health of the issuing of Larium to them while they were in the Armed Forces.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	208186
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>Mefloquine (commercially known as Lariam) is effective in the prevention and treatment of malaria and is licensed for use by the Medicines and Healthcare products Regulatory Agency, which regulates medication in the UK. The current product information for mefloquine states that neuropsychiatric adverse reactions may occur during treatment and includes warnings and precautions to minimise these risks. It also states that such adverse reactions may persist for months, or longer, even after discontinuation of the drug. It has not been established, however, that such adverse reactions may be permanent.</p><p> </p><p>Notwithstanding, in September 2016, the Ministry of Defence (MOD) established the mefloquine Single Point of Contact (SPOC) email and telephone line, for both current and former Service personnel who have concerns about their experience of mefloquine. Up to 15 January 2019, the mefloquine SPOC has received the following number of enquiries.</p><p> </p><table><tbody><tr><td><p><strong>Year</strong></p></td><td><p><strong>Enquiries from Serving Personnel</strong></p></td><td><p><strong>Enquiries from Veterans</strong></p></td><td><p><strong>Enquiries from Others</strong></p></td><td><p><strong>Total Number of Enquiries</strong></p></td></tr><tr><td><p><strong>2016</strong></p></td><td><p>24</p></td><td><p>33</p></td><td><p>22</p></td><td><p><strong>79</strong></p></td></tr><tr><td><p><strong>2017</strong></p></td><td><p>3</p></td><td><p>10</p></td><td><p>5</p></td><td><p><strong>18</strong></p></td></tr><tr><td><p><strong>2018</strong></p></td><td><p>4</p></td><td><p>7</p></td><td><p>6</p></td><td><p><strong>17</strong></p></td></tr><tr><td><p><strong>2019</strong></p></td><td><p>0</p></td><td><p>1</p></td><td><p>0</p></td><td><p><strong>1</strong></p></td></tr></tbody></table><p> </p><p>Individuals can be referred to the SPOC in a number of different ways, including by Service charities. The MOD does not maintain a record of all such referrals.</p><p> </p> answering member constituency Bournemouth East answering member printed Mr Tobias Ellwood grouped question UIN 208187 question first answered 17/01/2019 16:17:08 answering member 1487 label Biography information for Mr Tobias Ellwood
tabling member	252 label Biography information for Dr David Drew

1041258

registered interest
date	14/01/2019
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Armed Forces: Mefloquine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, how many (a) service personnel and (b) veterans his Department has referred to the Mefloquine Single Point of Contact in each year since it’s inception.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	208187
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>Mefloquine (commercially known as Lariam) is effective in the prevention and treatment of malaria and is licensed for use by the Medicines and Healthcare products Regulatory Agency, which regulates medication in the UK. The current product information for mefloquine states that neuropsychiatric adverse reactions may occur during treatment and includes warnings and precautions to minimise these risks. It also states that such adverse reactions may persist for months, or longer, even after discontinuation of the drug. It has not been established, however, that such adverse reactions may be permanent.</p><p> </p><p>Notwithstanding, in September 2016, the Ministry of Defence (MOD) established the mefloquine Single Point of Contact (SPOC) email and telephone line, for both current and former Service personnel who have concerns about their experience of mefloquine. Up to 15 January 2019, the mefloquine SPOC has received the following number of enquiries.</p><p> </p><table><tbody><tr><td><p><strong>Year</strong></p></td><td><p><strong>Enquiries from Serving Personnel</strong></p></td><td><p><strong>Enquiries from Veterans</strong></p></td><td><p><strong>Enquiries from Others</strong></p></td><td><p><strong>Total Number of Enquiries</strong></p></td></tr><tr><td><p><strong>2016</strong></p></td><td><p>24</p></td><td><p>33</p></td><td><p>22</p></td><td><p><strong>79</strong></p></td></tr><tr><td><p><strong>2017</strong></p></td><td><p>3</p></td><td><p>10</p></td><td><p>5</p></td><td><p><strong>18</strong></p></td></tr><tr><td><p><strong>2018</strong></p></td><td><p>4</p></td><td><p>7</p></td><td><p>6</p></td><td><p><strong>17</strong></p></td></tr><tr><td><p><strong>2019</strong></p></td><td><p>0</p></td><td><p>1</p></td><td><p>0</p></td><td><p><strong>1</strong></p></td></tr></tbody></table><p> </p><p>Individuals can be referred to the SPOC in a number of different ways, including by Service charities. The MOD does not maintain a record of all such referrals.</p><p> </p> answering member constituency Bournemouth East answering member printed Mr Tobias Ellwood grouped question UIN 208186 question first answered 17/01/2019 16:17:08 answering member 1487 label Biography information for Mr Tobias Ellwood
tabling member	252 label Biography information for Dr David Drew

1041262

registered interest
date	14/01/2019
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Domestic Abuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what assessment he has made of the risks of smart home and internet-connected devices being used to enable domestic violence.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	208306
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>Last year we launched a public consultation on the Government response to domestic abuse in which we asked about the risk of technology being used to perpetrate abuse.</p><p>We will be publishing a response to the consultation and draft Domestic Abuse Bill soon.</p><p>The Government will also shortly publish a white paper detailing how we will tackle online harms, including domestic abuse.</p><p>We have also provided Refuge with £250,000 of funding through the Tampon Tax to provide specialist nationwide support to staff and survivors who experience technologically facilitated abuse.</p> answering member constituency Louth and Horncastle answering member printed Victoria Atkins grouped question UIN 208307 question first answered 17/01/2019 16:26:14 answering member 4399 label Biography information for Victoria Atkins
tabling member	4621 label Biography information for Darren Jones

1041263

registered interest
date	14/01/2019
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Domestic Abuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what steps the Government is taking to prevent the misuse of smart home and internet-connected devices to enable domestic violence.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	208307
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>Last year we launched a public consultation on the Government response to domestic abuse in which we asked about the risk of technology being used to perpetrate abuse.</p><p>We will be publishing a response to the consultation and draft Domestic Abuse Bill soon.</p><p>The Government will also shortly publish a white paper detailing how we will tackle online harms, including domestic abuse.</p><p>We have also provided Refuge with £250,000 of funding through the Tampon Tax to provide specialist nationwide support to staff and survivors who experience technologically facilitated abuse.</p> answering member constituency Louth and Horncastle answering member printed Victoria Atkins grouped question UIN 208306 question first answered 17/01/2019 16:26:14 answering member 4399 label Biography information for Victoria Atkins
tabling member	4621 label Biography information for Darren Jones

1041268

registered interest
date	14/01/2019
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, whether her Department has plans to provide transitional protection to people that will naturally migrate to universal credit as a result of a change in circumstances.
tabling member constituency	North West Durham
tabling member printed	Laura Pidcock
uin	208310
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>Claimants only move from existing benefits to Universal Credit through natural migration when they experience a significant change in their circumstances that triggers a new claim to a benefit that Universal Credit replaces. Their entitlement is then calculated on the rules of their new benefit and their new circumstances. Transitional protection is designed to ensure those claimants who are moved onto Universal Credit without a change in circumstances receive the same level of entitlement to Universal Credit as they were entitled to on legacy benefits.</p><p> </p><p>As Universal Credit is simpler, the most recent estimates show that around 700,000 households will get entitlements they were not claiming under the legacy system, worth on average £285 per month.</p><p> </p><p>We have also introduced a number of measures to assist claimants during their transition to Universal Credit. Claimants who naturally migrate to Universal Credit can access a Universal Credit advance, which is worth up to 100 per cent of their indicative award and is available from the date of their claim. This advance is currently repayable over 12 months, but as announced in the 2018 Budget, from October 2021 the maximum repayment period will be extended to 16 months. Claimants may also be entitled to a two week Universal Credit Transitional Housing Payment. From July 2020 the Government is introducing a new two-week run on for income-related Employment and Support Allowance, Income Support and income-based Jobseeker’s Allowance.</p> answering member constituency Reading West answering member printed Alok Sharma question first answered 17/01/2019 17:05:50 answering member 4014 label Biography information for Sir Alok Sharma
tabling member	4665 label Biography information for Laura Pidcock